300404 博济医药
已收盘 07-22 15:00:00
资讯
新帖
简况
博济医药最新公告：公司及控股孙公司获得3项发明专利证书
证券之星 · 07-22 16:16
博济医药最新公告：公司及控股孙公司获得3项发明专利证书
博济医药(300404.SZ)：控股股东之一致行动人拟合计减持不超1.50%股份
智通财经网 · 07-12
博济医药(300404.SZ)：控股股东之一致行动人拟合计减持不超1.50%股份
博济医药新提交1件商标注册申请
证券之星 · 07-08
博济医药新提交1件商标注册申请
博济医药（300404）7月4日主力资金净卖出2410.98万元
证券之星 · 07-04
博济医药（300404）7月4日主力资金净卖出2410.98万元
博济医药（300404）6月26日主力资金净卖出1352.20万元
证券之星 · 06-26
博济医药（300404）6月26日主力资金净卖出1352.20万元
博济医药：公司2024年上半年订单情况将在定期报告中披露，请您关注公司后续公告
证券之星 · 06-24
博济医药：公司2024年上半年订单情况将在定期报告中披露，请您关注公司后续公告
博济医药（300404）6月21日主力资金净卖出1328.63万元
证券之星 · 06-21
博济医药（300404）6月21日主力资金净卖出1328.63万元
龙虎榜丨0.93亿资金抢筹博济医药，机构狂买思林杰（名单）
21财经 · 06-20
龙虎榜丨0.93亿资金抢筹博济医药，机构狂买思林杰（名单）
龙虎榜 | CRO概念升温！佛山系抢筹博济医药，上塘路、余哥齐抛长江通信
格隆汇 · 06-20
龙虎榜 | CRO概念升温！佛山系抢筹博济医药，上塘路、余哥齐抛长江通信
6月20日博济医药（300404）龙虎榜数据：游资量化打板、国君宜昌珍珠路、上塘路上榜
证券之星 · 06-20
6月20日博济医药（300404）龙虎榜数据：游资量化打板、国君宜昌珍珠路、上塘路上榜
6月20日博济医药涨停分析：干细胞，新冠药物，CAR-T疗法概念热股
证券之星 · 06-20
6月20日博济医药涨停分析：干细胞，新冠药物，CAR-T疗法概念热股
异动快报：博济医药（300404）6月20日9点41分触及涨停板
证券之星 · 06-20
异动快报：博济医药（300404）6月20日9点41分触及涨停板
CRO概念盘中拉升，博济医药等2只股票涨停
自选股智能写手 · 06-20
CRO概念盘中拉升，博济医药等2只股票涨停
博济医药：公司具备合成生物临床研发相关能力，具体客户信息属于公司商业机密，不便透露，敬请谅解
证券之星 · 06-14
博济医药：公司具备合成生物临床研发相关能力，具体客户信息属于公司商业机密，不便透露，敬请谅解
博济医药（300404）6月14日主力资金净买入123.78万元
证券之星 · 06-14
博济医药（300404）6月14日主力资金净买入123.78万元
博济医药(300404.SZ)：硫酸氨基葡萄糖氯化钠复盐取得化学原料药上市申请批准
智通财经 · 06-13
博济医药(300404.SZ)：硫酸氨基葡萄糖氯化钠复盐取得化学原料药上市申请批准
博济医药（300404）20万股限售股将于6月4日解禁，占总股本0.05%
证券之星 · 06-04
博济医药（300404）20万股限售股将于6月4日解禁，占总股本0.05%
博济医药：公司有多个处于不同研发阶段的自研项目，该类项目由公司自主立项，拥有自主知识产权
证券之星 · 06-03
博济医药：公司有多个处于不同研发阶段的自研项目，该类项目由公司自主立项，拥有自主知识产权
博济医药：5月31日组织现场参观活动，平安证券、凡德私募等多家机构参与
证券之星 · 06-03
博济医药：5月31日组织现场参观活动，平安证券、凡德私募等多家机构参与
博济医药(300404.SZ)拟10股派0.1元 于5月27日除权除息
智通财经 · 05-17
博济医药(300404.SZ)拟10股派0.1元 于5月27日除权除息
公司概况
公司名称：
博济医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2015-04-24
主营业务：
博济医药科技股份有限公司主要业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司主要服务包括临床研究服务、临床前研究服务、CDMO服务、其他咨询服务、临床前自主研发、技术成果转化服务等。公司在报告期内荣膺“2023中国医药服务最具竞争力企业10强”“2022中国医药CRO企业20强”“2022年度中国医药研发50强”等荣誉称号。
发行价格：
12.87
{"stockData":{"symbol":"300404","market":"SZ","secType":"STK","nameCN":"博济医药","latestPrice":7.49,"timestamp":1721631834000,"preClose":7.31,"halted":0,"volume":9903295,"delay":0,"floatShares":276000000,"shares":382000000,"eps":0.0762,"marketStatus":"已收盘","marketStatusCode":5,"change":0.18,"latestTime":"07-22 15:00:00","open":7.29,"high":7.53,"low":7.23,"amount":73437000,"amplitude":0.041,"askPrice":7.49,"askSize":403,"bidPrice":7.48,"bidSize":529,"shortable":0,"etf":0,"ttmEps":0.0762,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":7.31,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":8.04,"lowLimit":6.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":382207238,"pbRate":2.91,"roa":"--","roe":"1.72%","epsLYR":0.0657,"committee":-0.501731,"marketValue":2863000000,"floatMarketCap":2064000000,"peRate":98.293962,"changeRate":0.0246,"turnoverRate":0.0359,"status":0},"requestUrl":"/m/hq/s/300404/wiki","defaultTab":"wiki","newsList":[{"id":"2453753450","title":"博济医药最新公告：公司及控股孙公司获得3项发明专利证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2453753450","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453753450?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:16","pubTimestamp":1721636194,"startTime":"0","endTime":"0","summary":"博济医药公告，公司及控股孙公司赣江新区清芝康医药科技有限公司于近期获得国家知识产权局颁发的3项发明专利证书，分别为“一种雷沙吉兰中间体及其制备方法和应用”、“一种作为己酮糖激酶抑制剂的化合物及其应用”和“一种清咽利喉胶囊的制备方法”。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072200020244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2450535576","title":"博济医药(300404.SZ)：控股股东之一致行动人拟合计减持不超1.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2450535576","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450535576?lang=zh_cn&edition=full","pubTime":"2024-07-12 21:41","pubTimestamp":1720791691,"startTime":"0","endTime":"0","summary":"博济医药(300404.SZ)发布公告，公司控股股东、实际控制人王廷春的一致行动人...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1150450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2449111710","title":"博济医药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2449111710","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449111710?lang=zh_cn&edition=full","pubTime":"2024-07-08 12:40","pubTimestamp":1720413637,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日博济医药科技股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来博济医药科技股份有限公司新申请注册商标15件，截止目前公司共持有注册商标28件，另有48件商标尚在注册申请中。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800011673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2448413794","title":"博济医药（300404）7月4日主力资金净卖出2410.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448413794","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448413794?lang=zh_cn&edition=full","pubTime":"2024-07-04 15:26","pubTimestamp":1720077981,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月4日收盘，博济医药报收于7.32元，下跌5.79%，换手率7.36%，成交量20.29万手，成交额1.51亿元。7月4日的资金流向数据方面，主力资金净流出2410.98万元，占总成交额15.93%，游资资金净流出1050.37万元，占总成交额6.94%，散户资金净流入3461.35万元，占总成交额22.86%。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400024781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2446337737","title":"博济医药（300404）6月26日主力资金净卖出1352.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446337737","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446337737?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:25","pubTimestamp":1719386741,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月26日收盘，博济医药报收于8.08元，下跌0.86%，换手率12.62%，成交量34.79万手，成交额2.81亿元。6月26日的资金流向数据方面，主力资金净流出1352.2万元，占总成交额4.82%，游资资金净流入454.55万元，占总成交额1.62%，散户资金净流入897.65万元，占总成交额3.2%。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600025529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2445443027","title":"博济医药：公司2024年上半年订单情况将在定期报告中披露，请您关注公司后续公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2445443027","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445443027?lang=zh_cn&edition=full","pubTime":"2024-06-24 19:04","pubTimestamp":1719227058,"startTime":"0","endTime":"0","summary":"证券之星消息，博济医药(300404)06月24日在投资者关系平台上答复投资者关心的问题。投资者：请问公司上半年订单总量是多少?博济医药董秘：您好，公司2024年上半年订单情况将在定期报告中披露，请您关注公司后续公告。感谢您的关注！以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400027220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2445782871","title":"博济医药（300404）6月21日主力资金净卖出1328.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445782871","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445782871?lang=zh_cn&edition=full","pubTime":"2024-06-21 15:24","pubTimestamp":1718954666,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月21日收盘，博济医药报收于8.13元，下跌3.79%，换手率20.05%，成交量55.25万手，成交额4.47亿元。6月21日的资金流向数据方面，主力资金净流出1328.63万元，占总成交额2.97%，游资资金净流入4664.28万元，占总成交额10.43%，散户资金净流出3335.65万元，占总成交额7.46%。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100026535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2444922982","title":"龙虎榜丨0.93亿资金抢筹博济医药，机构狂买思林杰（名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2444922982","media":"21财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444922982?lang=zh_cn&edition=full","pubTime":"2024-06-20 19:10","pubTimestamp":1718881800,"startTime":"0","endTime":"0","summary":"其中，资金净买入最多的是博济医药，达0.93亿元，占总成交金额的19.47%。具体来看，机构净买入1股，净卖出17股。其中，机构净买入金额最多的是思林杰，当日收盘上涨20%，换手率为11.73%。北向资金净买入5股，净卖出5股6月20日，北向资金参与龙虎榜中的个股共有10只，合计净卖出305.86万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620191545aef5d532&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620191545aef5d532&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0225","BK0216","300404","688115"],"gpt_icon":0},{"id":"2444929249","title":"龙虎榜 | CRO概念升温！佛山系抢筹博济医药，上塘路、余哥齐抛长江通信","url":"https://stock-news.laohu8.com/highlight/detail?id=2444929249","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444929249?lang=zh_cn&edition=full","pubTime":"2024-06-20 18:53","pubTimestamp":1718880836,"startTime":"0","endTime":"0","summary":"今日龙虎榜净买入额前三为博济医药、中仑新材、传智教育","market":"sg","thumbnail":"https://img3.gelonghui.com/c048e-add14420-a277-49bb-b910-06c1c7d38f8e.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/c048e-add14420-a277-49bb-b910-06c1c7d38f8e.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/804457","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0002","003032","BK0122","BK0214","300462","002505","BK0250","BK0195","300404","BK0164","BK0111","BK0108","600345","BK0204","BK0216","BK0251","301565","BK0148"],"gpt_icon":0},{"id":"2444298908","title":"6月20日博济医药（300404）龙虎榜数据：游资量化打板、国君宜昌珍珠路、上塘路上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2444298908","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444298908?lang=zh_cn&edition=full","pubTime":"2024-06-20 17:15","pubTimestamp":1718874919,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2024年6月20日公布的交易公开信息显示，博济医药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2024年6月20日收盘，博济医药报收于8.45元，上涨20.03%，涨停，换手率21.18%，成交量58.35万手，成交额4.77亿元。量化打板、国君宜昌珍珠路、上塘路等知名游资榜上有名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000033860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2444266780","title":"6月20日博济医药涨停分析：干细胞，新冠药物，CAR-T疗法概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2444266780","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444266780?lang=zh_cn&edition=full","pubTime":"2024-06-20 15:33","pubTimestamp":1718868817,"startTime":"0","endTime":"0","summary":"证券之星消息，博济医药涨停收盘，收盘价8.45元。该股于9点41分涨停，5次打开涨停，截止收盘封单资金为362.98万元，占其流通市值0.16%。6月20日的资金流向数据方面，主力资金净流入1.02亿元，占总成交额21.35%，游资资金净流出4924.95万元，占总成交额10.32%，散户资金净流出5264.44万元，占总成交额11.03%。近5日资金流向一览见下表：该股为干细胞，新冠药物，CAR-T疗法概念热股。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000024535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2444239640","title":"异动快报：博济医药（300404）6月20日9点41分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2444239640","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444239640?lang=zh_cn&edition=full","pubTime":"2024-06-20 09:45","pubTimestamp":1718847927,"startTime":"0","endTime":"0","summary":"证券之星6月20日盘中消息，9点41分博济医药触及涨停板。目前价格8.45，上涨20.03%。其所属行业医疗服务目前上涨。领涨股为诺泰生物。该股为幽门螺杆菌概念，阿尔茨海默病，干细胞概念热股，当日幽门螺杆菌概念概念上涨1.33%，阿尔茨海默病概念上涨0.25%，干细胞概念上涨0.1%。6月19日的资金流向数据方面，主力资金净流出18.82万元，占总成交额0.65%，游资资金净流出362.78万元，占总成交额12.58%，散户资金净流入381.6万元，占总成交额13.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000014417.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2444366802","title":"CRO概念盘中拉升，博济医药等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2444366802","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444366802?lang=zh_cn&edition=full","pubTime":"2024-06-20 09:43","pubTimestamp":1718847828,"startTime":"0","endTime":"0","summary":"06月20日，CRO概念盘中拉升，截至09点43分，CRO概念整体指数上涨4.08%，报350.630点。从个股上来看，该概念的成分股中，百花医药、诺泰生物2只个股涨幅超过10%，博济医药等2只股票涨停，金凯生科、和元生物等5只股涨幅超过5%。从资金上来看，截止发稿，CRO概念主力净流入为5199.66万，其中诺泰生物受到资金热捧，主力净流入3787.13万；拉长时间线来看，该板块近20日主力资金净流入-41.05亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620094348941ef99a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620094348941ef99a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688076","300404","BK0239"],"gpt_icon":0},{"id":"2443462576","title":"博济医药：公司具备合成生物临床研发相关能力，具体客户信息属于公司商业机密，不便透露，敬请谅解","url":"https://stock-news.laohu8.com/highlight/detail?id=2443462576","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443462576?lang=zh_cn&edition=full","pubTime":"2024-06-14 17:05","pubTimestamp":1718355921,"startTime":"0","endTime":"0","summary":"证券之星消息，博济医药06月14日在投资者关系平台上答复投资者关心的问题。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400033056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2443661233","title":"博济医药（300404）6月14日主力资金净买入123.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443661233","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443661233?lang=zh_cn&edition=full","pubTime":"2024-06-14 15:23","pubTimestamp":1718349834,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月14日收盘，博济医药报收于7.08元，下跌2.88%，换手率3.72%，成交量10.25万手，成交额7302.31万元。6月14日的资金流向数据方面，主力资金净流入123.78万元，占总成交额1.7%，游资资金净流入787.63万元，占总成交额10.79%，散户资金净流出911.41万元，占总成交额12.48%。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061400023217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2443505006","title":"博济医药(300404.SZ)：硫酸氨基葡萄糖氯化钠复盐取得化学原料药上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2443505006","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443505006?lang=zh_cn&edition=full","pubTime":"2024-06-13 18:40","pubTimestamp":1718275247,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)公告，公司全资子公司广州博济生物医药科技园有限公司申报的“硫酸氨基葡萄糖氯化钠复盐”获得国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》。“硫酸氨基葡萄糖氯化钠复盐”可以用于生产相关剂型药品，具有抗炎作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1134943.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2440744281","title":"博济医药（300404）20万股限售股将于6月4日解禁，占总股本0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440744281","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440744281?lang=zh_cn&edition=full","pubTime":"2024-06-04 08:02","pubTimestamp":1717459379,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，博济医药于6月4日将有20.0万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.05%。本次解禁后，公司还有1.07亿股限售股份，占总股本27.9%。博济医药主营业务：为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060400010925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2440469963","title":"博济医药：公司有多个处于不同研发阶段的自研项目，该类项目由公司自主立项，拥有自主知识产权","url":"https://stock-news.laohu8.com/highlight/detail?id=2440469963","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440469963?lang=zh_cn&edition=full","pubTime":"2024-06-03 19:04","pubTimestamp":1717412649,"startTime":"0","endTime":"0","summary":"证券之星消息，博济医药06月03日在投资者关系平台上答复投资者关心的问题。2，有哪几款新药是自己公司正在研发的，专利属于自己公司的？投资者：请问董秘，公司具有强大的医药研发能力，问3个问题1，目前是否也有为自己公司研发的新药？公司将根据项目后续进展情况，严格按照相关法律法规的规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300024116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2440106248","title":"博济医药：5月31日组织现场参观活动，平安证券、凡德私募等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2440106248","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440106248?lang=zh_cn&edition=full","pubTime":"2024-06-03 07:15","pubTimestamp":1717370117,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年6月2日博济医药发布公告称公司于2024年5月31日组织现场参观活动，平安证券、凡德私募、华银私募、高新科控参与。公司也未产生临床前自主研发项目转让及技术成果转化服务收入，该类业务毛利率较高，同时研发、管理、销售等费用有所上升，因此净利润率有所下降。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300000151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","161027","300404"],"gpt_icon":0},{"id":"2436196969","title":"博济医药(300404.SZ)拟10股派0.1元 于5月27日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2436196969","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436196969?lang=zh_cn&edition=full","pubTime":"2024-05-17 21:05","pubTimestamp":1715951145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)公告，公司2023年年度权益分派拟：向全体股东每10股派发现金分红人民币0.1元(含税)。除权除息日为：2024年5月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","300404"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-04-24","address":"广东省广州市黄埔区科学城南翔一路62号(二,三,四,五)栋","stockEarnings":[{"period":"1week","weight":0.0317},{"period":"1month","weight":-0.0787},{"period":"3month","weight":0.0949},{"period":"6month","weight":-0.0222},{"period":"1year","weight":-0.2236},{"period":"ytd","weight":-0.162}],"companyName":"博济医药科技股份有限公司","boardCode":"AI0073","perCapita":"11400股","boardName":"研究和试验发展","registeredCapital":"38220万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 博济医药科技股份有限公司主要业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司主要服务包括临床研究服务、临床前研究服务、CDMO服务、其他咨询服务、临床前自主研发、技术成果转化服务等。公司在报告期内荣膺“2023中国医药服务最具竞争力企业10强”“2022中国医药CRO企业20强”“2022年度中国医药研发50强”等荣誉称号。","serverTime":1721672507809,"listedPrice":12.87,"stockholders":"24171人(较上一季度增加9.42%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博济医药,300404,博济医药股票,博济医药股票老虎,博济医药股票老虎国际,博济医药行情,博济医药股票行情,博济医药股价,博济医药股市,博济医药股票价格,博济医药股票交易,博济医药股票购买,博济医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}